ANTX vs AMGN: Which Stock is Better?

Side-by-side comparison of An2 Therapeutics Inc and Amgen Inc in 2026

Comparison Updated:

ANTX

An2 Therapeutics Inc

$2.85

AMGN

Amgen Inc

$369.53

Key Metrics Comparison

MetricANTXAMGNWinner
Market Cap$46.86M$198.16BAMGN
P/E RatioN/A26.66AMGN
EPS (TTM)$N/A$13.79AMGN
Revenue Growth0.0%0.1%AMGN
Gross Margin0.0%70.8%AMGN

Analyze ANTX

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ANTX or AMGN a better investment?

Comparing ANTX and AMGN: An2 Therapeutics Inc has a market cap of $46.86M while Amgen Inc has $198.16B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ANTX and AMGN?

ANTX (An2 Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ANTX or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ANTX or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for ANTX.

Which company is more profitable: ANTX or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for ANTX.

Which is the larger company: ANTX or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $198.16B compared to $46.86M for ANTX.

Should I buy ANTX or AMGN in 2026?

Both ANTX and AMGN have investment merit. ANTX trades at $2.85 while AMGN trades at $369.53. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ANTX and AMGN stock?

Key differences: Market Cap ($46.86M vs $198.16B), P/E Ratio (N/A vs 26.7x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).

Popular Stock Comparisons